Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Indian J Ophthalmol ; 69(6): 1563-1568, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34011742

ABSTRACT

PURPOSE: Rhino-orbital mucormycosis in times of ongoing COVID-19 pandemic. AIMS: The aim of the study was to document cases of rhino-orbital mucormycosis seen at our Regional Institute of Ophthalmology during COVID-19 (coronavirus disease 2019) times. METHODS: The study is a retrospective, institutional cohort, interventional study. It was carried out at our Regional Institute of Ophthalmology from September 2020 to mid-March 2021. All patients of biopsy-proven mucormycosis were enrolled in the study. The patients were subjected to complete history taking, ophthalmological examination, and imaging studies. The patients were treated via a multidisciplinary approach with intravenous liposomal amphotericin B and debridement of local necrotic tissue. Exenteration was done when indicated. A minimum 75-day follow-up period was accorded to all study patients. Statistical analysis was done using Chi-square test. A P value ≤0.05 was taken as significant. RESULTS: Thirty-one patients were seen, with a mean age of 56.3 years. The major risk factors included uncontrolled diabetes (96.7%) and COVID-19 positivity (61.2%), with concomitant steroid use in 61.2% patients. The most common presentation was diminution of vision (<6/60 in 80.64% patients) and ophthalmoplegia (77.4%). The most common imaging findings were orbital cellulitis (61.29%) and pansinusitis (77.4%). Intravenous liposomal amphotericin B was given to all patients for an average 18.93 days. Exenteration was required in (n = 4) 12.9% of cases. Twenty-eight patients recovered and were alive on follow-up. Mortality was seen in three patients. The presence of cerebral involvement and a HbA1c value of ≥8 were found to be significant in the prediction of survival of patients with mucormycosis. CONCLUSION: We present the largest institutional cohort of rhino-orbital mucormycosis patients during the ongoing COVID-19 pandemic era from our unique perspective.


Subject(s)
COVID-19 , Eye Infections, Fungal , Mucormycosis , Orbital Diseases , Antifungal Agents/therapeutic use , Debridement , Eye Infections, Fungal/diagnosis , Eye Infections, Fungal/drug therapy , Eye Infections, Fungal/epidemiology , Humans , Middle Aged , Mucormycosis/diagnosis , Mucormycosis/epidemiology , Mucormycosis/therapy , Orbital Diseases/drug therapy , Pandemics , Retrospective Studies , SARS-CoV-2
3.
Singapore Dent J ; 37: 27-32, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27916253

ABSTRACT

Orthodontic treatment often requires extraction or distalization for gaining space. With both treatment modalities, emphasis has always been given to the simplicity and effectiveness of the treatment, time required for each visit, cost and minimum requirement of the inventory. To accomplish this, various appliances and auxiliaries have been designed in the past of which sliding jigs are commonly used. They pose various clinical problems of which time to fabricate them for each patient is one as they cannot be stored in a prefabricated form. Hence a versatile smart sliding hook is introduced as a ready to use auxillary which is biomechanically efficient, convenient to patients, economical, time saving, easy to fabricate and can be prefabricated making it clinically very helpful for orthodontists in day to day practice.

SELECTION OF CITATIONS
SEARCH DETAIL
...